Commercial Access Only
Specimen SS-COM-BTR-0377 // BITTER
Receptor Block T4-IV-PH
Brassica napus
Canola/Rapeseed
Receptor Block SeriesTier 4
Target Trait
61.25
% reduction
Reported target: 61.25% bitter reduction
Technical Specifications
Genomic Edits
10
GC Content
(52%)
Construct Length
7,200 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Pathway Edits
- TAS2R38 complete null
- Glucosinolate biosynthesis KO
- Myrosinase suppression
Key Interventions
TAS2R38 complete gene deletionGlucosinolate biosynthesis gene knockoutMyrosinase gene silencing construct
Application Domains
PharmaceuticalResearch
Intended Use
Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.